Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03026127 · ClinicalTrials.gov registry record · NA
A Novel Cognitive Reappraisal Intervention for Suicide Prevention
A NA study, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- NA
- Development phase
- 107
- Enrollment target
NCT03026127 is a NA study that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 107 participants.
The verdict
NCT03026127, a NA study, has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- NA
- Development phase
- 107 participants
- Enrollment target
Study Summary
The goal of this trial is to refine and test a novel emotion-regulation based psychosocial intervention designed to reduce suicide risk in middle-aged and older adults (50-90 years old) who have been discharged after a suicide-related hospitalization (i.e. for suicidal ideation or suicide attempt).
Interventions
- BEHAVIORAL Supportive Therapy
- BEHAVIORAL Cognitive Reappraisal Intervention for Suicide Prevention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 107 participants |
| Start Date | 2017-03-28 |
| Est. Completion | 2024-10-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03026127
The ClinicalTrials.gov registry entry for NCT03026127 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 107 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Supportive Therapy is the first listed.
NCT03026127 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03026127 about?
NCT03026127 is a clinical study titled "A Novel Cognitive Reappraisal Intervention for Suicide Prevention". The goal of this trial is to refine and test a novel emotion-regulation based psychosocial intervention designed to reduce suicide risk in middle-aged and older adults (50-90 years old) who have been discharged after a suicide-related hospitalization (i.e. for suicidal ideation or suicide attempt).
What is the current status of trial NCT03026127?
This trial is currently completed. It is a NA study. The enrollment target is 107 participants. The study started on 2017-03-28. Estimated completion is 2024-10-03.
What interventions are being tested in trial NCT03026127?
The interventions under investigation include: Supportive Therapy (BEHAVIORAL), Cognitive Reappraisal Intervention for Suicide Prevention (BEHAVIORAL).
Who is sponsoring clinical trial NCT03026127?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.